Search Results 151-160 of 6031 for albumin

1. A Study to Evaluate Pevonedistat and Venetoclax Plus Azacitidine in Adults with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy - Mayo Clinic

   Albumin >2.7 g/dL;; WBC count < 25 × 10^9/L. Patients who are cytoreduced with leukapheresis or with hydroxyurea may be enrolled if they meet the eligibility ...

2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

   Albumin ≥ 2.8 g/dL. Renal. Serum creatinine ≤ 1.5 × ULN; or; Creatinine clearance of ≥ 30 mL/min as estimated by the Cockcroft-Gault equation. Female and ...

3. Flu vaccine: Safe for people with egg allergy? - Mayo Clinic

   Yes, you can get a flu shot even if you are allergic to eggs. Serious reactions to the small amount of egg protein in flu vaccines are unlikely.

4. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

   Albumin ≥ g/dL;; Amylase and lipase ≤.5× ULN (≤× ULN if amylase or lipase is isolated with neither clinical nor radiographic signs of pancreatitis). Last ...

5. EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx - Mayo Clinic

   Serum albumin <3.0 g/dL unless prothrombin time is within the normal range. Pregnancy or lactation. For female patients of childbearing potential (defined ...

6. A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic

   Albumin ≥ 3.0 g/dL. Acceptable renal function: Serum creatinine within normal limits, OR calculated creatinine clearance 60 mL/min/1.73 m^2 for patients ...

7. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

   ... albumin preparation. Involved in the planning and/or conduct of the study (applies to CSL staff, staff at the study site, and third-party vendors) ...

8. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   - Serum albumin >= 30 g/L (3.0 g/dL) (obtained =< 28 days prior to randomization) - For subjects not receiving therapeutic anticoagulation: international ...

9. Respiratory Physiology of Escalating Doses of Nalbuphine Extended-Release Tablets in Patients with IPF - Mayo Clinic

   Liver Function: Total Bilirubin >3mg/dL [>50umol/L] and Serum Albumin <2.8g/dl at screening. Subjects with a history of over sedation or a current clinical ...

10. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Serum calcium within institutional normal range, or serum albumin-corrected calcium within institutional normal range (if serum albumin is outside of the ...